Literature DB >> 6360058

Sedative-hypnotic drug use and ageing.

K Morgan.   

Abstract

Behavioural disadvantages associated with the use of sedative-hypnotic drugs in the elderly are considered in relation to four aspects of drug usage reported in the epidemiological literature between 1960 and 1982, viz. (1) the prevalence of drug usage; (2) the type of drug, and the dose used; (3) the typical duration of usage; and (4) the typical frequency of usage. Demographic characteristics of elderly hypnotic users are also examined. The pattern and prevalence of usage over the past 20 yr show many consistent features. In particular, the prevalence of drug usage among the elderly has remained relatively high, especially within institutional settings. Sex differences in the prevalence of sleeping drug usage, frequently reported for elderly populations, appear to be related to bereavement, health status, and age. The advanced age of hypnotic drug users, however, does not appear to influence the choice of hypnotic drug prescribed. Moreover, drugs and dosages typically prescribed, and the duration and frequency of use typically reported, do not reflect a consistent approach to the problem of minimizing some of the adverse behavioural consequences associated with sedative-hypnotic drug use in the elderly.

Mesh:

Substances:

Year:  1983        PMID: 6360058     DOI: 10.1016/0167-4943(83)90022-5

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  10 in total

Review 1.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

2.  Longitudinal study on the consumption of analgesics, tranquilizers and hypnotics by healthy Swiss men over a 13-year period (1972-1985).

Authors:  H R Wacker; R Battegay; C Schlösser
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

3.  Effects of repeated dose nitrazepam and lormetazepam on psychomotor performance in the elderly.

Authors:  K Morgan
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Problems and pitfalls in the use of benzodiazepines in the elderly.

Authors:  W H Kruse
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

5.  Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home.

Authors:  K Morgan; H Dallosso; S Ebrahim; T Arie; P H Fentem
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-27

Review 6.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

7.  Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice.

Authors:  M A Cormack; K G Sweeney; H Hughes-Jones; G A Foot
Journal:  Br J Gen Pract       Date:  1994-01       Impact factor: 5.386

Review 8.  Patterns of sleep disorders and sedative hypnotic use in seniors.

Authors:  E Mullan; C Katona; M Bellew
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

9.  Controlled comparison of the characteristics of long-term benzodiazepine users in general practice.

Authors:  R J Simpson; K G Power; L A Wallace; M H Butcher; V Swanson; E C Simpson
Journal:  Br J Gen Pract       Date:  1990-01       Impact factor: 5.386

10.  Factors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studies.

Authors:  Philippe Voyer; David Cohen; Sylvie Lauzon; Johanne Collin
Journal:  BMC Nurs       Date:  2004-08-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.